Onderzoeker
Tessa Kerre
- Trefwoorden:celtherapie, Hematologie, CAR-T cel therapie, primaire immuundeficiënties, stamceltransplantatie, Immunologie, Bibliotherapie
- Disciplines:Hematologie, Immunologie niet elders geclassificeerd
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Diagnostische Wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → 30 sep 2021 - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 2010 → 30 sep 2018 - Vakgroep Klinische Biologie, Microbiologie en Immunologie (Departement)
Lid
Vanaf1 okt 1997 → 30 sep 2018
Projecten
1 - 5 of 5
- Chimerische antigen receptor onconventionele T-celtherapie (CAR-oT) voor de behandeling van solide tumorenVanaf1 nov 2023 → HedenFinanciering: FWO junior postdoctoraal mandaat
- Optimalisatie van CD70-gerichte adoptieve cel therapieVanaf1 nov 2023 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
- Digitale innovatie voor mens en samenlevingVanaf1 jan 2020 → HedenFinanciering: BOF - onderzoeksorganisaties
- CancerInMotionVanaf15 jul 2019 → 15 mei 2021Financiering: IOF - technologie concept exploratie
- Behandeling minimale ziekte positieve acute myeloïde leukemie patiëntenVanaf1 jan 2015 → 31 dec 2018Financiering: VZW en equivalenten
Publicaties
11 - 20 van 70
- Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic stem cell transplantation(2022)Volume: 57
Auteurs: J. L. Pinana, G. Tridelo, A. Xhaard, L. Wendel, J. Montoro, L. Vazquez, I. Heras, P. Ljungman, M. Mikulska, U. Salmen-Niemi, et al.
Pagina's: 60 - 61 - Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50(2022)
Auteurs: Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, Nadezhda Camacho-Ordonez, Hassan Abolhassani, Laia Alsina, Faranaz Atschekzei, Delfien Bogaert, Siobhan O. Burns, Joseph A. Church, et al.
- Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2, cohort B(2022)Volume: 40
Auteurs: Niels W. C. J. van de Donk, Mounzer E. Agha, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan Mark Schecter, Kevin C. De Braganca, Helen Varsos, et al.
Aantal pagina's: 1 - Phase 2 CARTITUDE-2 study (cohort B) : updated clinical data and biological correlative analyses of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy(2022)Volume: 22
Auteurs: Mounzer Agha, Niels W. C. J. van de Donk, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Helen Varsos, et al.
Pagina's: S408 - S409 - Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)(2022)
Auteurs: Xavier Poire, Carlos Graux, Aurelie Ory, Julie Herman, Frederic Baron, Helene Schoemans, Philippe Lewalle, Ann De Becker, Dries Deeren, Zwi Berneman, et al.
Pagina's: 116 - 118 - Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy(2022)
Auteurs: Elena Catanzaro, Eleonora Turrini, Tessa Kerre, Simon Sioen, Ans Baeyens, Alessandra Guerrini, Mohamed Lamin Abdi Bellau, Gianni Sacchetti, Guglielmo Paganetto, Dmitri Krysko, et al.
- CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment(2022)Volume: 197
Auteurs: Niels W. C. J. Van de Donk, Michel Delforge, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Jens Hillengass, Sebastien Anguille, Tessa Kerre, Wilfried Roeloffzen, Jordan M. Schecter, et al.
Pagina's: 118 - 119 - Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer : a study of the Chronic Malignancies Working Party of the EBMT(2022)
Auteurs: Mitja Nabergoj, Katya Mauff, Dietrich Beelen, Arnold Ganser, Nicolaus Kröger, Friedrich Stölzel, Jürgen Finke, Jakob Passweg, Jan Cornelissen, Natalie Schub, et al.
Pagina's: 1072 - 1078 - Ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2 cohort B 18-month follow-up(2022)Volume: 140
Auteurs: Niels W. C. J. Van de Donk, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre, Wilfried W. H. Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Carolyn C. Jackson, et al.
Pagina's: 7536 - 7537 - Fecal microbiota transplantation in the treatment of acute gastrointestinal graft-versus-host disease : a retrospective survey of the transplant complications working party of EBMT(2022)Volume: 57
Auteurs: J. Bilinski, G. W. Basak, K. Halaburda, D. Wu, O. Goloshchapov, S. Maury, A. Tanase, G. Van Gorkom, Anke Delie, Tessa Kerre, et al.
Pagina's: 186 - 187